NA
IHE icon

NewEdge Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

NewEdge Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.4K Sell
762
-635
-45% -$57.2K ﹤0.01% 3017
2026
Q1 		$121K Buy
1,397
+434
+45% +$38K ﹤0.01% 2706
2025
Q4 		$81.7K Sell
963
-249
-21% -$19.9K ﹤0.01% 2820
2025
Q3 		$87.9K Hold
1,212
– – ﹤0.01% 2643
2025
Q2 		$79.4K Sell
1,212
-951
-44% -$61.9K ﹤0.01% 2502
2025
Q1 		$153K Sell
2,163
-23
-1% -$1.6K ﹤0.01% 2178
2024
Q4 		$144K Sell
2,186
-831
-28% -$57.2K ﹤0.01% 2175
2024
Q3 		$213K Sell
3,017
-816
-21% -$56.9K ﹤0.01% 1980
2024
Q2 		$254K Sell
3,833
-324
-8% -$21.2K ﹤0.01% 1802
2024
Q1 		$282K Sell
4,157
-187
-4% -$12.4K ﹤0.01% 1675
2023
Q4 		$268K Buy
4,344
+3,387
+354% +$199K ﹤0.01% 1592
2023
Q3 		$56.5K Sell
957
-300
-24% -$18.4K ﹤0.01% 2059
2023
Q2 		$75K Hold
1,257
– – ﹤0.01% 1951
2023
Q1 		$73.4K Sell
1,257
-90
-7% -$5.42K ﹤0.01% 1856
2022
Q4 		$84 Buy
+1,347
New +$81K ﹤0.01% 3395
2018
Q4 		– Sell
-5,520
Closed -$309K – 669
2018
Q3 		$309K Sell
5,520
-441
-7% -$24.1K 0.02% 486
2018
Q2 		$300K Buy
+5,961
New +$296K 0.03% 412

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

NewEdge Advisors's IHE Position: Q2 2026 in Review

NewEdge Advisors reduced its iShares US Pharmaceuticals ETF (IHE) stake by 45% in Q2 2026, selling an estimated $57.2K and leaving 762 shares worth $75.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

NewEdge Advisors first reported a position in IHE in Q2 2018 and has held it in 17 quarters since. The position peaked at $309K in Q3 2018. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • NewEdge Advisors held 762 shares of iShares US Pharmaceuticals ETF worth $75.4K as of Q2 2026.
  • NewEdge Advisors sold 635 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $57.2K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3017 holding.
  • NewEdge Advisors first reported a position in iShares US Pharmaceuticals ETF in Q2 2018 and has held it in 17 quarters since.
  • NewEdge Advisors's iShares US Pharmaceuticals ETF position peaked at $309K in Q3 2018.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.